rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
IL23R is an IBD susceptibility gene, but has no epistatic interaction with CARD15 and SLC22A4/5. rs1004819 is the major IL23R variant associated with CD in the German population, while the p.Arg381Gln IL23R variant is a protective marker for CD and UC.
|
17786191 |
2007 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
GWASDB |
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
|
18587394 |
2008 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
This data provides an explanation for the protective role of R381Q in CD and may lead to the development of improved therapeutics for autoimmune disorders like CD.
|
22022372 |
2011 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Variants of CARD15 (3020insC and R702W) and IL23R (rs1004819, rs11209026, and rs1088967) were associated with CD.
|
18200510 |
2008 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Specifically the G149R, V362I, and R381Q IL23Rα chain variants are linked to protection against the development of Crohn disease and ulcerative colitis in humans.
|
26887945 |
2016 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
NOD2 p.L1007insC was associated with OFG+CD (P = 0.023) and IL23R p.R381Q with all OFG (P = 0.031).
|
27306066 |
2016 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
GWASCAT |
Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.
|
17804789 |
2007 |
rs11209026
|
|
G |
0.900 |
GeneticVariation |
GWASDB |
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300.
|
22936669 |
2013 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
One hundred and eighty unrelated IBD patients [57 Crohn's disease (CD) and 123 ulcerative colitis (UC)] and 186 healthy controls were genotyped for the following known genetic susceptibility variants: NOD2 - Arg702Trp (rs2066844), Gly908Arg (rs2066845) and Leu1007insC (rs2066847), as well as IL23R - Arg381Gln (rs11209026) and ATG16L1 - Thr300Ala (rs2241880).
|
20082483 |
2010 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
An uncommon coding variant (rs11209026, c.1142G>A, p.Arg381Gln) confers strong protection against Crohn's disease, and additional noncoding IL23R variants are independently associated.
|
17068223 |
2006 |
rs11209026
|
|
G |
0.900 |
GeneticVariation |
GWASDB |
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci.
|
22412388 |
2012 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
|
17894849 |
2007 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
We also provide further evidence for association of rs11209026</span> with UC and a report of an additive effect between IL23R and CARD15 genotypes in CD.
|
17894849 |
2007 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Finally, rs8074524 and rs10758669 in Crohn's disease and rs11209026 in ulcerative colitis were associated with disease-related operation.
|
27852544 |
2016 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Polymorphisms R702W, G908R, and 3020insC of NOD2/CARD15; rs2241880 A/G of ATG16L1, and rs11209026 (R381Q) of IL23R gene were assessed in 110 childhood-onset CD, 364 adult-onset CD, and 539 healthy individuals.
|
20380008 |
2010 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Recent studies have shown that a nonsynonymous single-nucleotide polymorphism (SNP) (Arg381Gln; rs11209026) in the interleukin-23 receptor (IL-23R) gene on chromosome 1p31 is associated with Crohn's disease and psoriasis.
|
18383363 |
2008 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
An association of variants in the genes encoding the interleukin 23 receptor (IL23R, p.Arg381Gln, rs11209026), and the autophagy-related gene 16-like 1 (ATG16L1, p.Ala197Thr, rs2241880) with Crohn disease (CD) was identified by whole genome association studies, and subsequently confirmed by other works.
|
19590455 |
2009 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Our study provides additional support for the strong protection of the rs11209026 (p.Arg381Gln) variant against paediatric CD.
|
20192940 |
2010 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The rare Q allele of IL23R rs11209026 polymorphism was underrepresented in both paediatric and adult CD cases (P = 0.0018 and P = 0.04, respectively) and no difference was observed between the childhood and the adult cohort.
|
20380008 |
2010 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
The rs11209026 SNP, which is the most strongly associated with Crohn's disease, was not associated with GD or GO in our data set.
|
18073300 |
2008 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
One, an uncommon coding variant (rs11209026) in the gene encoding for the interleukin-23 receptor (IL23R), conferred strong protection against CD.
|
18047540 |
2008 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
Our meta-analysis supports that two polymorphisms (Arg381Gln and rs7517847) within the IL-23R gene may be considered to be protective factors against developing CD.
|
20157760 |
2010 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
A highly significant association with CD was observed, with the strongest signal at coding variant Arg381Gln (allele frequency, 2.5% in CD vs 6.2% in controls [P = 1.1 x 10(-12)]; odds ratio, 0.38; 95% confidence interval, 0.29-0.50).
|
17484863 |
2007 |
rs11209026
|
|
G |
0.900 |
GeneticVariation |
GWASCAT |
A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300.
|
22936669 |
2013 |
rs11209026
|
|
|
0.900 |
GeneticVariation |
BEFREE |
After Bonferroni correction for multiple testing, both the homozygous and the heterozygous variant genotypes of IL23R G>A(rs11209026) (OR(CD,adj): 0.38, 95% CI: 0.21-0.67, p = 0.03; OR(IBD,adj) 0.43, 95% CI: 0.28-0.67, p = 0.007) and PTPN22 1858 G>A(rs2476601) (OR(CD,unadj) 0.54, 95% CI: 0.41-0.72, p = 7*10-4; OR(IBD,unadj): 0.61, 95% CI: 0.48-0.77, p = 0.001) were associated with reduced risk of CD.
|
24971461 |
2014 |